Table 2. Clinical outcome.
| Characteristics | All N=450 |
LABC N=306 |
IBC N=144 |
P-value* |
|---|---|---|---|---|
| Pathological complete response (pCR) | 1 | |||
| no | 309 | 210 | 99 | |
| yes | 141 | 96 | 45 | |
| pCR, rate | 31% (95CI 27-36) | 31% (95CI 26-37) | 31% (95CI 24-40) | |
| median follow-up, months (range) | 52.1 (5.49-187.37) | 51.01 (5.49-187.37) | 57.07 (7-172.16) | 0.109 |
| MFS event | 140 (31%) | 76 (25%) | 64 (45%) | 4.52E-05 |
| 5-year MFS | 68% [95CI 63–73] | 74% [95CI 68-79] | 57% [95CI 49-67] | 1.33E-04 |
| LRRFS event | 33 (7%) | 15 (5%) | 18 (13%) | 6.05E-03 |
| 5-year LRRFS | 92% [95CI 89-95] | 95% [95CI 92-97] | 86% [95CI 80-93] | 3.73E-03 |
| OS event | 81 (18%) | 32 (11%) | 49 (34%) | 5.62E-09 |
| 5-year OS | 82% [95CI 78-86] | 88% [95CI 83-92] | 69% [95CI 62-78] | 5.21E-07 |
* Fisher’s exact test for the discrete variables and log-rank test for survival rates.